Detalhe da pesquisa
1.
Black Patients with Metastatic Castrate-Resistant Prostate Cancer Have a Shorter Time Interval Between PSA and Clinical Progression on Novel Hormonal Therapies plus Avelumab.
Oncologist
; 28(3): 276-e158, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36210487
2.
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Prostate
; 81(7): 433-439, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792945
3.
Changes in taste and smell of food during prostate cancer treatment.
Support Care Cancer
; 29(6): 2807-2809, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33566164
4.
Biomarkers for Programmed Death-1 Inhibition in Prostate Cancer.
Oncologist
; 24(4): 444-448, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30541755
5.
Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer.
BMC Cancer
; 19(1): 524, 2019 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31151428
6.
Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer.
Oncologist
; 23(7): 791-797, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700205
7.
Long-Term Disease Control Using Taxane/Platinum-Based Chemotherapy in CDK12-Mutated Advanced Prostate Cancer.
Oncologist
; 25(9): e1421-e1422, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32592623
8.
Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer.
Clin Cancer Res
; 27(6): 1623-1630, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451978
9.
Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer.
Oncotarget
; 11(1): 15-21, 2020 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32002120
10.
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer.
Cancer Treat Res Commun
; 24: 100193, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702615
11.
Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort.
Front Oncol
; 10: 581189, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33194712
12.
TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 18(2): 148-154, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822380
13.
Relationship between serum markers and volume of liver metastases in castration-resistant prostate cancer.
Cancer Treat Res Commun
; 20: 100151, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128516
14.
Characterizations of Clinical and Therapeutic Histories for Men With Prostate Cancer-Specific Mortality.
Clin Genitourin Cancer
; 14(2): 139-48, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26703881
15.
Exceptional Duration of Radium-223 in Prostate Cancer With a BRCA2 Mutation.
Clin Genitourin Cancer
; 15(1): e69-e71, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27726949